Jinfeng Wang
Shijiazhuang, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
A blood-biomarker based CTC-ALRI score predicts recurrence in hepatocellular carcinoma patients following curative resection.
Journal: Frontiers in oncology
Published: January 15, 2026
Aberrant activation of the PI3K/AKT/HIF‑1α pathway promotes glycolysis and lenvatinib resistance in liver cancer.
Journal: Molecular medicine reports
Published: February 13, 2025
Identification and validation of a lenvatinib resistance-related prognostic signature in HCC, in which PFKFB4 contributes to tumor progression and lenvatinib resistance.
Journal: BMC gastroenterology
Published: December 18, 2024
Transarterial Chemoembolization Combined With PD-1 Inhibitors Plus Lenvatinib Showed Improved Efficacy for Treatment of Unresectable Hepatocellular Carcinoma Compared With PD-1 Inhibitors Plus Lenvatinib.
Journal: Technology in cancer research & treatment
Published: May 10, 2023
Sarcopenia and Systemic Inflammation Response Index Predict Response to Systemic Therapy for Hepatocellular Carcinoma and Are Associated With Immune Cells.
Journal: Frontiers in oncology
Published: January 13, 2022
Clinical significance of novel identified high-frequency tumor-specific peptides associated signature in predicting disease status of gastric cancer patients.
Journal: BioFactors (Oxford, England)
Published: June 02, 2021
18F-Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography Metabolic Parameters Before and After Neoadjuvant Chemotherapy Can Predict the Postoperative Prognosis of Locally Advanced Gastric Cancer.
Journal: Cancer biotherapy & radiopharmaceuticals
Published: August 14, 2020
Matrine prevents the early development of hepatocellular carcinoma like lesions in rat liver.
Journal: Experimental and therapeutic medicine
Published: January 12, 2019
Combined intra-arterial and intravenous chemotherapy for unresectable, advanced gastric cancer has an improved curative effect compared with intravenous chemotherapy only.
Journal: Oncology letters
Published: April 25, 2017
Showing 1-11 of 11
Last Updated: 09/26/2026